Replies to post #252907 on Biotech Values

[novicetrader]

Dew-LQDA/UTHR-do you think LQDA has valid reason to challenge the FDA on today's decision to delay their final Approval of YUTREPIA after expiration of 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025?
https://finance.yahoo.com/news/u-fda-grants-tentative-approval-100000113.html